Caricamento...
Long-term outcome of infliximab optimization for overcoming immunogenicity in patients with inflammatory bowel disease
BACKGROUND: Preliminary data suggest that treatment optimization can reverse immunogenicity and regain response in patients with IBD and secondary loss of response (SLR) to anti-TNF therapy due to anti-drug antibodies. However, data regarding the long-term outcome of these patients are scarce. AIMS:...
Salvato in:
| Pubblicato in: | Dig Dis Sci |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823777/ https://ncbi.nlm.nih.gov/pubmed/29340807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-018-4917-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|